Picture of Bio Vitos Pharma AB logo

BIOVIT Bio Vitos Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Hemcheck Receives Preliminary Positive Results From Clinical Evaluation Study

June 20 (Reuters) - Hemcheck Sweden AB  HEMC.ST :
    * CLINICAL EVALUATION STUDY COMPLETED WITH VERY GOOD RESULTS
AT A
UNIVERSITY HOSPITAL IN FRANCE
    * HEMCHECK, TOGETHER WITH A UNIVERSITY HOSPITAL IN SOUTHERN
FRANCE, HAS SUCCESSFULLY COMPLETED AN EVALUATION STUDY OF
HEMCHECK'S PRODUCTS (V-TEST), AT LOCAL CLINICAL LABORATORY
    * THIS STUDY CONFIRMS THAT TESTS HAVE HIGH PERFORMANCE AND
THAT
THEY HAVE STRONG CORRELATION WITH PROVEN REFERENCE METHODS WHILE
AT SAME TIME CONFIRM USEFULNESS OF PRODUCTS FOR E.G. DIAGNOSTIC
USE
    * RESULTS ARE PRELIMINARY AND WILL BE FINALIZED AND THEN
PUBLISHED
IN A SCIENTIFIC JOURNAL, AFTER WHICH MORE DETAILED INFORMATION
CAN BE PROVIDED

Source text for Eikon:  ID:nWkr8LZsWs 
Further company coverage:  HEMC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Bio Vitos Pharma AB

See all news